Literature DB >> 32359134

Time to benefit and harm of intensive blood pressure treatment: insights from SPRINT.

Ashok Krishnaswami1,2, Eric D Peterson3, Parag Goyal4, Dae Hyun Kim5, Michael W Rich6, Sei J Lee7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 32359134      PMCID： PMC9034202          DOI： 10.1093/ehjqcco/qcaa035

Source DB:  PubMed          Journal:  Eur Heart J Qual Care Clin Outcomes        ISSN： 2058-1742


× No keyword cloud information.
  4 in total

Review 1.  Rationalizing prescribing for older patients with multimorbidity: considering time to benefit.

Authors:  Holly M Holmes; Lillian C Min; Michael Yee; Ravi Varadhan; Jenny Basran; William Dale; Cynthia M Boyd
Journal:  Drugs Aging       Date:  2013-09       Impact factor: 3.923

2.  Incorporating lag time to benefit into prevention decisions for older adults.

Authors:  Sei J Lee; Rosanne M Leipzig; Louise C Walter
Journal:  JAMA       Date:  2013-12-25       Impact factor: 56.272

3.  Efficacy and Safety of Intensive Blood Pressure Therapy Using Restricted Mean Survival Time-Insights from the SPRINT Trial.

Authors:  Ashok Krishnaswami; Eric D Peterson; Dae Hyun Kim; Parag Goyal; Michael W Rich
Journal:  Am J Med       Date:  2020-02-13       Impact factor: 4.965

4.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Authors:  Jackson T Wright; Jeff D Williamson; Paul K Whelton; Joni K Snyder; Kaycee M Sink; Michael V Rocco; David M Reboussin; Mahboob Rahman; Suzanne Oparil; Cora E Lewis; Paul L Kimmel; Karen C Johnson; David C Goff; Lawrence J Fine; Jeffrey A Cutler; William C Cushman; Alfred K Cheung; Walter T Ambrosius
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245
  4 in total
  3 in total

Review 1.  A clinical algorithm to determine target blood pressure in the elderly: evidence and limitations from a clinical perspective.

Authors:  Jinho Shin; Kwang-Il Kim
Journal:  Clin Hypertens       Date:  2022-06-15

2.  Time to Clinical Benefit of Intensive Blood Pressure Lowering in Patients 60 Years and Older With Hypertension: A Secondary Analysis of Randomized Clinical Trials.

Authors:  Tao Chen; Fang Shao; Kangyu Chen; Yang Wang; Zhenqiang Wu; Yongjuan Wang; Yanpei Gao; Victoria Cornelius; Chao Li; Zhixin Jiang
Journal:  JAMA Intern Med       Date:  2022-06-01       Impact factor: 44.409

3.  How Low Should You Go in the Presence of Frailty?

Authors:  Michelle C Odden; Timothy S Anderson
Journal:  Hypertension       Date:  2021-12-08       Impact factor: 9.897
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.